CompletedNot Applicable

Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy

Egypt42 participantsStarted 2022-06-01

Plain-language summary

The aim of this study is to evaluate the outcome of perioperative immune-nutrition with glutamine, arginine and fish oil in patients undergoing radical cystectomy as regards to enhancement of healing, increasing immunity and improving overall health status.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with CT showing bladder mass with radiological staging of T2 or T3.
✓. Patients pathologically proven to have cancer bladder.
✓. Patients undergoing radical cystectomy with ileal conduit.
✓. The American Society of Anesthesiologists Physical Status classification system (ASA PS) of 1, 2 or 3.

Exclusion criteria

✕. Coagulopathy.
✕. Distant metastasis.
✕. Body mass index less than 18.5.
✕. Relevant food allergies.
✕. Severe renal and hepatic insufficiency.

What they're measuring

Postoperative complications

Timeframe: 30 days

Wound healing

Timeframe: 30 days

infectious complications

Timeframe: 30 days

Trial details

NCT IDNCT05822518

SponsorMenoufia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-30

View on ClinicalTrials.gov More Cancer, Bladder trials